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Abstract: Wound dressings are high performance and high value products which can improve the
regeneration of damaged skin. In these products, bioresorption and biocompatibility play a key role.
The aim of this study is to provide progress in this area via nanofabrication and antimicrobial natural
materials. Polyhydroxyalkanoates (PHAs) are a bio-based family of polymers that possess high
biocompatibility and skin regenerative properties. In this study, a blend of poly(3-hydroxybutyrate)
(P(3HB)) and poly(3-hydroxyoctanoate-co-3-hydroxy decanoate) (P(3HO-co-3HD)) was electrospun
into P(3HB))/P(3HO-co-3HD) nanofibers to obtain materials with a high surface area and good
handling performance. The nanofibers were then modified with silver nanoparticles (AgNPs) via
the dip-coating method. The silver-containing nanofiber meshes showed good cytocompatibility
and interesting immunomodulatory properties in vitro, together with the capability of stimulating
the human beta defensin 2 and cytokeratin expression in human keratinocytes (HaCaT cells), which
makes them promising materials for wound dressing applications.
Keywords: polyhydroxyalkanoates; eco-friendly nanofibers; wound dressings; low-impact biomedi-
cal applications; immunomodulation; defensin; keratinocytes
1. Introduction
Nanofibers have received much attention in biomedical applications lately. These ma-
terials have a high surface area, porosity, versatility in material choice and morphological
similarities to the naturally occurring extracellular matrix, which enhances cell attachment
and proliferation, transport of nutrients, gas exchange and waste excretion. Furthermore,
the physical and/or chemical properties of the electrospun nanofibers can be modified by
encapsulation and or immobilization of bio-active species to receive specific biological reac-
tions [1]. The unique properties of nanofibers have attracted particular attention for wound
healing applications. Contemporary wound dressings should accelerate healing with a
pleasing aesthetic result [2,3]. For this purpose, they should be hemostatic, absorb exudates,
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manage moisture balance and thermal insulation, protect against infections and be low cost.
Researchers have shown that nanofibers which function well as wound dressings have
good hemostasis, absorbability and semi-permeability [2,4]. Moreover, multifunctional
dressings can easily be designed by the incorporation of multiple therapeutic compounds.
Nanofibers are most frequently produced by the electrospinning technique, as it
is an inexpensive and reliable method to create fibers with diameters ranging from the
nanometer scale to a few micrometers [5,6]. Many different natural and synthetic polymers
have been electrospun for applications such as tissue engineering, wound dressing and
drug delivery [1,7–11]. For such applications, biodegradable and biocompatible polymers
are more favorable over others, as they metabolize into biocompatible degradation products
in the human body.
Polyhydroxyalkanoates (PHAs) are fully biodegradable polymers which are biosyn-
thesized with high purity by a wide range of Gram-positive and Gram-negative bacteria
from inexpensive waste carbon sources [12–17]. Moreover, they are biocompatible, non-
toxic, insoluble in water, piezoelectric, thermoplastic and/or elastomeric and available
at an industrial scale. These properties make them suitable for various applications such
as the packaging industry, medicine, pharmacy, agriculture, the food industry, and the
production of paints. Nowadays, PHAs are extensively investigated for their use in
biomedical applications, including drug delivery, wound healing, vascular grafting, or-
thopedic applications, and urological stents [18–20]. PHAs with 3–5 carbon atoms such as
poly(3-hydroxybutyrate) (P(3HB)) and poly(4-hydroxybutyrate) (P(4HB)) are considered
as short chain length PHAs (scl-PHAs). Medium chain length PHAs (mcl-PHAs) con-
tain 6–14 carbon atoms, which include homopolymers such as poly(3-hydroxyhexanoate),
P(3HHx), poly(3-hydroxyoctanoate), P(3HO) and heteropolymers such as P(3HHx-co-3HO).
Scl-PHAs typically have a higher molecular weight, crystallinity and brittleness, while mcl-
PHAs are more elastomeric. Mcl-PHAs and their copolymers are preferred for biomedical
applications where flexible biomaterials are required, such as heart valves or controlled
drug delivery [21,22]. The structural diversity of mcl-PHAs is higher than scl-PHAs, so they
can be easily designed according to what is needed, as the monomer content of PHAs affects
their physical and chemical characteristics. However, one drawback of the mcl-PHAs for
electrospinning is their low glass transition temperature (Tg), which limits their spinnability
and causes sticky and fused fibers. Several groups have investigated the electrospinning
of different scl-PHAs, including P(3HB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
P(3HB-co-3HV), poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P3HB-co-4HB), poly(3-
hydroxybutyrate-co-3-hydroxyhexanoate) P(HB-co-3HHx) and poly(3-hydroxybutyrate-co-
3-hydroxyvalerate-co-3-hydroxyhexanoate) P(3HB-co-3HV-co-3HHx) [23–29]. Recent exam-
ples by Liu and coworkers introduced both single-nozzle and coaxial electrospinning of
mcl-PHA poly (3-hydroxyoctanoate-co-3-hydroxyhexanoate) P(3HO-co-3HHx) nanofibers
by blending with a scl-PHA, P(3HB-co-3HV) [30,31]. Electrospun PHA fibrous meshes can
be surface-functionalized with micro-/nanoparticles to introduce specific functionalities,
such as chitin nanofibrils, useful in skin regeneration and repair [32].
In recent years, metal nanoparticle-containing electrospun nanofibers have attained
widespread attraction for various applications such as bio/gas sensing, catalysis, and
antimicrobial wound dressings [33,34]. Among many metal nanoparticles and their metal
oxides, such as copper, gold, ZnO, CuO and TiO2, silver nanoparticles (AgNPs) have
been investigated most intensively in the medical field due to their excellent chemical
stability, high conductivity, catalytic activity, localized surface plasma resonance as well
as their antibacterial and anti-inflammatory properties and efficacy against a broad range
of bacteria found in chronic wounds [35,36]. AgNPs show lower toxicity compared to
conventional silver compounds [37,38]. Several studies on the combination of silver
nanoparticles with PHAs have been performed by Lagaron and coworkers including
the production of AgNPs by chemical reduction in P(3HB-co-3HV) suspensions [39], in
situ stabilized nanosilver-based antimicrobial P(3HB-co-3HV) nanocomposites [40] and
an antimicrobial active multilayer system composed of a P(3HB-co-3HV) film coated with
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P(3HB-co-3HV)/AgNPs nanofibers [41], in which silver nitrate was chemically reduced to
generate AgNPs.
Antimicrobial biomaterials are very useful in a number of biomedical applications
related to many diseases, especially those concerning or deriving from skin damage [42,43].
Some types of wounds cannot self-heal completely, often due to the presence of concurrent
pathologies. Therefore, they tend to become chronic via self-sustaining inflammatory
processes, which degrade the growth factors deputed to healing, thus leading to recurrent
infections. In those cases, the application of specific biomaterial dressings able to stimulate
and/or accelerate the wound healing process can be of great importance to restore the
normal native tissues. For this reason, the search for highly biocompatible and antibacterial
materials able to modulate the immune reaction in a successful way is essential, and
electrospun nanofibers are gaining popularity in this field.
The biological mediators of innate immunity and inflammation are cytokines, bio-
logical molecules that act as soluble mediators of natural immunity and the immune re-
sponse [44]. The most frequently studied cytokines are several proinflammatory cytokines,
interleukin 1 (IL 1), tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), interleukin 8 (IL-8),
and the anti-inflammatory cytokine transforming growth factor β (TGF-β). In response
to irritant products and injuries the epidermal keratinocytes also secrete antimicrobial
peptides. Human β-defensin 2 (HBD-2) acts as an endogenous antibiotic against bacteria,
fungi and the envelope of some viruses, and can be activated as an innate immune response
by endogenous stimuli, infections or wounds [45]. Inflammation is essential to initiate the
wound repair, but it must be modulated over time to achieve a normal uncomplicated heal-
ing. Therefore, new bioactive materials, which are able to stimulate intrinsic antimicrobial
activity of cells while modulating the inflammatory process, are interesting candidates
as wound dressings. In addition, an improved coating method based on AgNPs can be
promising for reducing the toxicity while improving the antimicrobial activity.
The goal of this paper was to design nanofibrous wound dressings from bio-based
polymers (i.e., PHAs) in order to contribute to reducing environmental pollution and to
provide antimicrobial features to the PHA membranes using AgNPs. For the production
of nanofibers with silver nanoparticles, there have been suggested some chemical and
physical methods such as in-situ reduction of silver nanoparticle precursor (generally sil-
ver nitrate) to silver nanoparticles in a polymer solution [46–48], application of UV light
to nanofibers that contain silver nanoparticle precursor [49,50], etc. In in-situ reduction
process, N,N dimethylformamide (DMF) is used as a reductant, which is a very harmful
solvent, and the process itself takes a long time, approximately 5–10 days. Moreover, it is
not possible to achieve a 100% successful reduction of silver precursor to silver nanopar-
ticles. In addition, in the physical reduction processes, UV-light is used and it is not a
very cheap technique in terms of the consumed energy and time. However, dip-coating
method enables the obtaining of silver nanoparticle containing nanofibers via a simple,
cheap, environmentally friendly technique for biomedical applications. To the best of
our knowledge, PHA-based nanofibers were not functionalized with silver nanofibers via
dip-coating. For this purpose, we proposed an alternative method for AgNP deposition
via dip-coating technique using a colloidal silver solution that allows a timesaving, simple
and reagent-free way to produce antimicrobial P(3HB)/P(3HO-co-3HD) membranes. We
first examined the electrospinning of elastomeric P(3HO-co-3HD) using an eco-friendly
solvent mixture, but wet fibers were obtained due to the low Tg of the polymer. In order
to tune the electrospinnability, elasticity and mechanical properties, we prepared blends
of the elastomeric mcl-PHA, P(3HO-co-3HD) with scl-PHA, P(3HB) which has a higher
Tg and brittleness. Since scl-P(3HB) could not be dissolved with the previously used
eco-friendly solvent system, a chlorinated solvent mixture was used for the electrospinning
of P(3HB)/P(3HO-co-3HD) blends. The electrospun P(3HB)/P(3HO-co-3HD) nanofibers
were then modified with AgNPs via a dip-coating method. The antimicrobial properties
of the modified nanofibers were investigated and were found to be promising for wound
dressing applications. Conventional wound dressings such as acrylic, polyethylene or
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polypropylene-based pads usually suffer from a lack of recycling—they are either inciner-
ated or landfilled. In our study, the bio-based material of the nanofibrous mats offer organic
composting as an option for waste management. Moreover, the high polarity of the PHAs
and the porosity of the fibrous meshes will provide advantages such as easy and proper
impregnation of the agents, odor suppression, efficacy of treatment and easy removal of the
dressing from the skin. Having a properly functional bioactive and biocompatible wound
dressing which combines a reduced environmental impact with remarkable antibacterial
properties would greatly improve the portfolio of wound dressing products.
2. Materials and Methods
The P(3HO-co-3HD) was created within 15 L bioreactors (Applikon Biotechnology,
Tewkesbury, UK) containing a 10 L mixture of Pseudomonas mendocina CH50 and 20 g/L
glucose. Subsequently, a two-stage batch fermentation was applied such as described in
Basnett et al., 2020 [51]. The production of P(3HB) was carried out with a similar protocol.
However, this time Bacillus subtilis OK2 was used with single-stage batch fermentation. The
P(3HB) produced exhibited a Mw of 796 ±40 kDa, 2–4% elongation at break, Tg = 2.9 ◦C,
and the mcl-PHA P(3HO-co-3HD) exhibited a Mw of 350 ± 60 kDa, 440% elongation at
break, and Tg between 48 ◦C and 44 ◦C. A specific purification protocol was applied to ob-
tain ultra-pure PHAs as described in Basnett et al., 2020. Aqueous colloidal silver solution
(4000 ppm, size of the AgNPs in the solution was between 10 and 80 nm) was purchased
from Argenol Laboratories (Zaragoza, Spain). Lithium bromide (LiBr), ethanol (EtOH), and
Dulbecco’s phosphate-buffered saline were purchased from Sigma-Aldrich (Saint Louis,
MO, USA). The HaCaT cell line was provided by CLS-Cell Lines Service, Eppenheim, Ger-
many. Dulbecco’s Modified Essential Medium (DMEM), L-glutamine, MgCL2, penicillin,
streptomycin (penstrep) and fetal calf serum were bought from Invitrogen (Carlsbad, CA,
USA). Alamar Blue was obtained from Thermo Fisher Scientific (Waltham, MA, USA). LC
Fast Start DNA Master SYBR Green kit was provided by Roche Applied Science (Basel,
Switzerland). The solvents used for solubility studies and electrospinning include acetone,
anisole, 2-butanol, butyl acetate, chloroform, dichloromethane, diethyl ether, dimethyl
carbonate, ethyl acetate, and methyl ethyl ketone, which were purchased from Sigma-
Aldrich and have a purity above 98%. PanCK monoclonal antibody, hydrogen peroxidase,
citrate buffer, standard avidin–biotin conjugated complex and DAB staining were provided
by Dako (from Agilent; Carpinteria, CA, USA). Formalin was bought from Bio-Optica
(Milan, Italy).
The nanofibers were analyzed morphologically by an FEI Quanta 200 F FE-SEM and a
Phenom ProX SEM (Waltham, MA, USA). The samples were coated with gold using a sput-
ter coater (Balzer Union SKD030, Balzers, Liechtenstein) prior to analysis. The nanofiber
diameters were calculated via ImageJ software (1.51v). Additionally, the histogram graphs
of the nanofibers were obtained from the measured diameter values by using the Origin
software (Origin 2017). The average nanofiber diameter and the standard deviation were
based on 50 measurements per sample. In addition, the weight percentage (wt%) and
the atomic percentage of silver nanoparticles on the silver nanoparticle-coated samples
were determined by an FEI Quanta 200F FE-SEM-EDX. An attenuated total reflectance
Fourier transform infrared (ATR-FTIR) spectrometer (Nicolet iS50, Waltham, MA, USA)
from Thermo Scientific was used to record the IR spectra of the samples. The spectra were
collected after 32 scans for each sample between 4000 cm−1 and 400 cm−1 with a wavenum-
ber resolution of 4 cm−1. Ultraviolet–visible spectroscopy of the nanofiber samples was
examined by a Perkin Elmer Lambda 900 UV-Vis spectrophotometer in reflection using an
integrated sphere (Spectralon Labsphere 150 mm, New Hampshire, USA). Spectra were
recorded in the range of 200–800 nm with a reflection data interval of 4 nm. The obtained
reflection was converted into Kubelka–Munk (K–M). Electrospinning of P(3HO-co-3HD)
was performed in a climate chamber (Weiss WK-340/40) with temperature of 10–40 ◦C
and relative humidity (RH) of 10–40%. The nanofibrous membranes were dip-coated in an
aqueous colloidal silver solution at room temperature. This coating was performed at a
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speed of 170 mm/min with the aid of computer-regulated dip-coating equipment (KSV
Instruments). The entire coating process happened in a clean room (class 100,000/1000).
The samples were dip-coated in a silver solution (4000 ppm) by immersion for 1 min 3
successive times.
2.1. Optimization of Electrospinning Parameters for P(3HO-co-3HD) Nanofibers and
Electrospinning of P(3HB)/P(3HO-co-3HD) Nanofibers
P(3HO-co-3HD) was electrospun in a solvent mixture containing anisole (30%, v/v),
acetone (35%, v/v) and ether (35%, v/v) with a flow rate of 0.5 mL/h, tip-to-collector
distance of 40 cm and voltage of 40 kV in a humidity (relative humidity of 10–40%) and
temperature-controlled (10–40 ◦C) climate chamber. A quantity of 0.002 g/mL LiBr was
added into the electrospinning solution to increase the conductivity.
Since P(3HO-co-3HD) is elastomeric and has a low Tg, which creates difficulties in
spinning such as fused fibers, it was blended with P(3HB) that has higher Tg and tends to
produce fibers with better morphology.
Polymeric solutions at 11 wt% and 5.5 wt% of P(3HB)/P(3HO-co-3HD) (1/10, w/w)
and a 5 wt% of P(3HB)/P(3HO-co-3HD) (1/3, w/w) were prepared in a chloroform/2-
butanol (70/30, v/v) solvent system and stirred for 24 h at room temperature. A quantity of
0.002 g/mL LiBr was added into the electrospinning solution to increase the conductivity.
The relative humidity (RH) was 38 ± 2.1% and the temperature was 22 ± 1.6 ◦C during the
electrospinning process for the 5 wt% of P(3HB)/P(3HO-co-3HD) solution.
For the P(3HB)/P(3HO-co-3HD) (1/10, w/w) polymer solutions, a voltage of 40 kV,
a 40 cm tip-to-collector distance and a flow rate of 0.5 mL/h was used. Nanofibers were
collected on a chitosan non-woven carrier that was backed by an aluminum foil.
The drawback of P(3HB) is its brittleness. As the aim was to produce nanofibers with
good morphology without losing the elasticity, the ratio of P(3HB)/P(3HO-co-3HD) was
selected as 1/3 (w/w), which was suitable to produce uniform and continuous fibers with
low diameters that were also not brittle.
For the P(3HB)/P(3HO-co-3HD) (1/3, w/w) solution, electrospinning parameters of
20 kV applied voltage, 15 cm distance between the needle tip and the collector, 1 mL/h
feed-rate were applied, and nanofibers were collected on a flat collector which was covered
by aluminum foil.
During the electrospinning process, in order to minimize fiber fused morphologies
due to an insufficient evaporation of the solvent, the tip-to-collector distance had to be
larger than 10 cm. Thus, for all electrospinning experiments, the distances between the
needle tip-to collector were varied in the range of 15–40 cm.
2.2. Silver Deposition on P(3HB)/P(3HO-co-3HD) Nanofibers
The P(3HB)/P(3HO-co-3HD) nanofibers were modified with an aqueous colloidal
silver solution (4000 ppm) via a dip-coating technique. The size of the nanoparticles in the
solution ranged between 10 and 80 nm. For dip-coating, the nanofibrous scaffolds with
a size of 30 mm× 60 mm were prepared, clamped from two sides and hung on the portable
holder of the dip-coater. The samples were dipped into the colloidal silver solution and
withdrawn with a speed of 170 mm/min. Three different protocols were tried, including
dipping and withdrawing immediately, dipping and withdrawing after 1 min and dipping
and withdrawing 3 successive times. In all cases, the withdrawing speed was the same and
the samples were washed with distilled water and dried.
2.3. Biological Evaluation of P(3HB)/P(3HO-co-3HD) Nanofibers
Blank and AgNP-containing P(3HB)/P(3HO-co-3HD) nanofibers have been sterilized
in EtOH overnight, then DPBS was used to rinse the nanofibers three times before usage.
DMEM was used to culture the cell line HaCaT combined with 1% Penstrep, 1% glutamine
and 10% serum of calf fetuses at 37 ◦C, combined with 5% CO2 and humidified air. The
cells were plated on the glass slides coated with the fibrous samples and cultured for 6 h
and 24 h.
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To perform Alamar Blue assay, the HaCaT cells at a confluence of 80% have been
incubated with the samples for a duration of 24 h. At the endpoint, 0.5 mg/mL resazurine
was included, followed by another 4 h incubation to enable the metabolic reaction. The
supernatants’ absorbance (λ) was then determined with the aid of a spectrophotometer
(Victor3; Perkin Elmer, Waltham, MA, USA) and a reading at two wavelengths (i.e., 570 nm
and 600 nm). At the end, the relative reduction of Alamar Blue (%ABred) was deter-
mined by associating the absorbance and the dye’s molar extinction coefficients at the
aforementioned wavelengths, following the protocol suggested by the manufacturer. The




117, 216·λs(570 nm) − 80, 586·λs(600 nm)
)
(
155, 677·λc(600 nm) − 14, 652·λc(570 nm)
) (1)
The results obtained are expressed as %ABred, which is related to metabolically ac-
tive cells. The skin immunomodulatory properties of Ag-loaded and plain P(3HB)/P(3HO-
co-3HD) nanofibers were determined. The HaCaT cells were seeded within 12-well plates
up to a confluence of 80%; therefore, they were incubated for 6 h and 24 h with the glass
slides coated by the nanofibers (n = 3). At these respective moments, all the RNA was
isolated with the aid of Trizol. Subsequently, 1 µM of RNA was reverse-transcribed into
the complementary DNA (cDNA). This was carried out with the aid of random hexamer
primers at 42 ◦C for a duration of 45 min such as stated within the guidelines of the
manufacturer. A LC FAST START DNA Master SYBR Green kit was used to carry out the
quantitative reverse transcriptase polymer chain reaction (qRT-PCR). A quantity of 10 ng of
total RNA and 2 µL of cDNA were used in a final volume of 20 µL with 3 mM MgCl2 and
0.5 µM sense and antisense primers, such as depicted in Table 1 [32,33]. The expression
of TNF-α, TGF-β and HBD-2 as well as the interleukins IL-1α, IL-1β, IL-6 and IL-8 was
evaluated with qRT-PCR.
Table 1. The details of the quantitative reverse transcriptase polymer chain reaction (qRT-PCR). This includes operational
conditions, gene, primer sequences, and product [32,33].




5 s at 95 ◦C, 8 s at 55 ◦C,




5 s at 95 ◦C, 14 s at 58 ◦C,




5 s at 95 ◦C, 13 s at 56 ◦C,




5 s at 94 ◦C, 6 s at 55 ◦C,




5 s at 95 ◦C, 6 s at 57 ◦C,




5 s at 94 ◦C, 9 s at 60 ◦C,




5 s at 94 ◦C, 6 s at 63 ◦C,
10 s at 72 ◦C for 50 cycles 198
Finally, the glass slides covered by the nanofibers were seeded with HaCaT cells and
their capability of expressing cytokeratin was evaluated via immunocytochemistry (IHC).
The antigenicity was retrieved by treating the slides at 100 ◦C in a steamer with 10 mMol
citrate buffer (pH 6.0) for 60 min. Subsequently, the sections were immersed for 20 min in
a methanol solution with 0.3% hydrogen peroxidase to stop the activity of the endogenous
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peroxidase. Afterwards, nonspecific binding was reduced by incubation in a 2.5% blocking
serum. The specimens were incubated for 90 min at 37 ◦C with the primary antibody
PanCK. Both the processes of the standard avidin–biotin conjugated complexing and the
subsequent DAB staining were automated according to the surgical pathology guidelines
(BenchmarkDX; Ventana Systems, Harvard, MA, USA). The immunopositive epithelial cells
were highlighted by the brown precipitate on the cell membranes and in their cytoplasm.
Negative controls were obtained by subtraction of primary antibody during the standard
IHC procedure.
3. Results and Discussion
3.1. Eco-Friendly Electrospinning of P(3HO-co-3HD)
The non-toxic biosourced poly(3-hydroxyoctanoate-co-3-hydroxydecanoate) P(3HO-co-
3HD) is a biocompatible and biodegradable polymer with high ductility (440% elongation
at break), which makes it an ideal candidate for body contact medical applications such as
wound dressings [19]. To a large extent, the polymer owes its flexibility and low Tg (below
−40 ◦C) to its medium chain length alkane side-groups and its copolymeric nature [23].
These properties also contribute to the high solubility (>10 wt%) at room temperature we
found for a wide range of eco-friendly solvents [52,53], including acetone, anisole, butyl
acetate, diethyl ether, dimethyl carbonate, ethyl acetate, and methyl ethyl ketone. However,
electrospinning of these solutions based on green solvents mostly results in bad quality
fiber depositions with wet and fused nanofibers and reduced porosity (Figure 1a,b). The
non-ecofriendly but fast evaporating solvents chloroform and dichloromethane result in
a more porous nanofibrous membrane, although the fibers are still fused together, such as
is shown in Figure 1c.
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Figure 1. Electrospinning P(3HO-co-3HD) with ethyl acetate (a). Solutions based on green solvents
(such as ethyl acetate, butyl acetate, dimethyl carbonate, methyl ethyl ketone) mostly result in bad
quality fiber depositions with the nanofibers being fused together. Fast evaporating solvents such as
diethyl ether result in porous membranes (b), but still the porosity is reduced. Fast evaporating halo-
genated solvents such as dichloromethane (c) and chloroform result in a porous nanofiber structure.
To circumvent carcinogenic halogenated solvents, P(3HO-co-3HD) nanofibers can be
obtained from an eco-friendly solvent mixture that contains anisole, acetone and ether
(Figure 2b,c). The electrospinning parameters for the nanofibers were investigated in terms
of concentration, relative humidity (RH), temperature and solvent composition.
A sufficient polymer concentration is necessary to avoid the residual solvent fusing the
fibers after deposition, and induce film formation (Figure 2a,b). The RH of the environment
is deemed less critical, as similar fiber morphologies are observed at a RH of 10% and 40%
(Figure 2b,c).
The electrospinning temperature does have a major effect on the fiber morphology,
as an increase in temperature causes the fibers to become thicker due to the increased
solvent evaporation rate that prevents the fibers stretching during the initial stages of
electrospinning (Figure 3a,d). SEM images show that with electrospinning a 10 wt% P(3HO-
co-3HD) solution in an anisole/acetone/ether (30%/35%/35%) mixture at 10 ◦C and RH of
40%, fine nanofibers are obtained with an average diameter of 300 nm (Figure 3b), while at
25 ◦C the fibers have a diameter of 440 nm (Figure 3e) and at 40 ◦C the fibers become 2 µm
thick and fuse completely. The fusing of the fibers at higher temperatures can be attributed
Materials 2021, 14, 4907 8 of 17
to the low specific fiber surface area of thick fibers, which increases drying times due to
a reduced solvent evaporation rate. The polymer also approaches its melting temperature
(57 ◦C), which additionally reduces its rate of crystallization/solidification (Figure 3g).
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The importance of solvent composition was evaluated using 10% P(3HO-co-3HD)
solution in three different anisole/acetone/ether solvent compositions (40%/30%/30%),
(30%/35%/35%) and (10%/45%/45%) with a RH of 40%.
The (30%/35%/35%) anisole/acetone/ether mixture (Figure 3b,e) was found to be an
optimum condition which gave more uniform nanofibers. The slow evaporating anisole
needs to be balanced with the fast-evaporating acetone and ether, which is on the one hand
because the electrospinning process requires an evaporation rate of the solution that is
sufficiently high (Figure 3b,e) by limiting the anisole content to avoid a fused morphology
(Figure 3c,f). On the other hand, the slow evaporating anisole prevents clogging at the
nozzle tip and leads to a lower fiber diameter because the solvent allows the fibers to
stretch more during the initial stages of the electrospinning process. These thin fibers
(Figure 3b,e) have a higher specific fiber surface area that is in contact with the environment
in comparison to solutions with less anisole (Figure 3a,d). The higher contact surface
promotes solvent evaporation, both during electrospinning as well as after deposition onto
the collector, hence avoiding fused fibers.
Although the neat P(3HO-co-HD) nanofibers become increasingly fused at longer
electrospinning times (>30 min) at the same spot, preventing their applicability as a stand-
alone nanofiber membrane, they could also be electrospun onto a chitosan carrier as a thin
layer (Figure 3h). Thus, eco-friendly conditions can be preferred in cases where thin layers
of neat P(3HO-co-3HD) nanofibers are sufficient. One of the main reasons for the fused
morphology of the nanofibers at room temperature electrospinning is the low Tg of P(3HO-
co-3HD). In order to eliminate this effect, a blend of P(3HB) and P(3HO-co-3HD) can be
used, which is discussed in the subsequent subsection.
3.2. Blend Electrospinning of P(3HB)/P(3HO-co-3HD)
While standalone P(3HO-co-3HD) nanofibrous membranes cannot be electrospun at
room temperature conditions and always need a backing carrier structure, the brittle P(3HB)
has a proven track record of electrospinnability with halogenated solvents, avoiding fiber
fusion altogether [26,54–56]. Nevertheless, P(3HB) has an elongation at break of less than
4%, making it too brittle for single usage as nanofibrous membranes in wound dressing
applications. Hence, within this section a synergetic electrospinning mixture is aimed for
by blend electrospinning to combine some of the flexibility of P(3HO-co-3HD) with the
standalone and non-fused characteristics of P(3HB) nanofibers.
Ideally, a low toxicity solvent system is used for blend electrospinning P(3HB) and
P(3HO-co-3HD). This requires the substitution of typical P(3HB) electrospinning solvents
such as chloroform or dichloromethane. For this, we could turn to the literature on
P(3HB) extraction (and PHA extraction in general) from bacterial cultures, which is, how-
ever, mostly based on the same chlorinated solvents [57–59]. To date, multiple attempts
have been made to bypass these halogenated solvents for P(3HB) extraction from bacte-
rial cultures and use less toxic solvents instead, such as butyl acetate, ethyl acetate [60],
acetone/ethanol/propylene carbonate mixtures [61], anisole and cyclohexanone [62]. How-
ever, temperatures of 100 ◦C and above are always needed. Based on the literature review,
we have tried various solvents and solvent mixtures for dissolving P(3HB) including ben-
zyl alcohol, anisole, cyclohexanone, acetone, methyl ethyl ketone, dimethyl carbonate,
ethyl acetate, their mixtures with anisole or benzyl alcohol, mixture of esters and alco-
hols, mixtures with DMSO and water. At 100 ◦C, the polymer could be dissolved in pure
dimethyl carbonate, as well as solvent mixtures, including: ethanol/anisole (70%/30%),
anisole/isopropanol/H2O (40%/50%/10%), anisole/DMSO (60%/40%) and dimethyl car-
bonate/DMSO (80%/20%). However, immediate solidification occurs at room temperature,
making electrospinning (at room temperature) impossible.
Hence, for a successful electrospinning, a chlorinated solvent was included, and pure
P(3HB) nanofibers were electrospun from a chloroform/2-butanol (70/30, v/v) mixture,
which results in neat but brittle nanofibers with an average diameter of 775 ± 106 nm.
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When electrospinning a blend of both polymers with the chloroform/2-butanol (70/30,
v/v) solvent system, the ratio of P(3HB)/P(3HO-co-3HD) should be considered carefully
as a high amount of P(3HB) can cause loss of elasticity, leading to brittle fibers, but a high
P(3HO-co-3HD) may lead to fused fibers at large membrane thicknesses.
Initially, the blend was electrospun from 5.5 wt and 11 wt% P(3HB)/P(3HO-co-3HD)
(1/10, w/w) solutions onto chitosan carriers as wound dressing candidates, with average
diameters of 470 ± 330 nm and 3420 ± 2100 nm, respectively (Figure 4a,b).
Figure 4. P(3HB)/P(3HO-co-HD) nanofibers with a concentration of (a) 5.5 wt%, (b) 11 wt%
nanofibers, on chitosan carriers that are visible as thick fibers in the background. (c) SEM image and
(d) histogram of the optimized P (3HB)/P(3HO-co-3HD) nanofibers.
Optimization studies on the electrospinning of P(3HB)/P(3HO-co-3HD) blends were
continued to obtain nanofibers that are as fine as possible while remaining flexible and bead-
free. For this, a 5 wt% of P(3HB)/P(3HO-co-3HD) (1/3, w/w) was prepared in chloroform/2-
butanol (70/30, v/v) (Figure 4c,d). The average diameter of the neat P(3HB)/P(3HO-
co-3HD) nanofibers was 410 ± 180 nm with bead-free and homogenous morphology
(Figure 4c). These nanofibers are used for AgNP immobilization in Section 3.3. The average
diameter of nanofibers synthesized by different solution conditions are summarized in
Table S1.
3.3. Modification and Characterization of the P(3HB)/P(3HO-co-3HD) Nanofibers with AgNPs
The modification and characterization processes were conducted on the P(3HB)/P(3HO-
co-3HD) nanofibers based on the optimum 1/3 (w/w) blends. The P(3HB)/P(3HO-co-3HD)
nanofibers were modified with silver nanoparticles (AgNPs) via a dip-coating technique to
provide anti-microbial properties to the scaffolds. For this purpose, the nanofibers were
first dipped into a water solution with colloidal silver (4000 ppm), containing particles in
a size range of 10–80 nm, and subsequently taken out at a speed of 170 mm/min.
Three different protocols were examined in order to achieve the best silver deposition.
In the first trial, P(3HB)/P(3HO-co-3HD) nanofibers were dipped in a beaker containing
the colloidal silver solution and taken out immediately, followed by washing with distilled
water and drying. In the second trial, the nanofibers were immersed into the aqueous
silver solution and kept in the solution for 1 min. Afterwards, the samples were taken
out, washed with distilled water and left to dry. In the last protocol, the nanofibers were
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dipped into the aqueous silver solution and taken out immediately for three successive
times, followed by washing and drying.
SEM images showed that the first protocol allowed the immobilization of the Ag-
NPs. However, the distribution of the nanoparticles was not homogeneous and dense
(Figure S4a). It was also observed that the second protocol did not contribute to achieving
an intense and uniform dispersion of AgNPs over the P(3HB)/P(3HO-co-3HD) nanofibers
(Figure S4b). Additionally, the nanoparticles had the tendency to agglomerate due to the in-
creased immersion time. The most homogeneous and intense immobilization of the AgNPs
was achieved using the third protocol. Although some minor agglomerations were still pos-
sible, a homogeneous dispersion of the silver nanoparticles over P(3HB)/P(3HO-co-3HD)
nanofibers was clearly observed (Figure 5). Subsequently, the presence of silver nanoparti-
cles on the P(3HB)/P(3HO-co-3HD) nanofibers was confirmed by EDX characterization
and determined as 18 wt% and 5.3 atomic percentage, respectively.
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FTIR-ATR spectra of neat P(3HB)/P(3HO-co-3HD) nanofibers and AgNP-loaded 
P(3HB)/P(3HO-co-3HD) nanofibers are given in Figure S3. There is no considerable shift 
of the peaks in the presence of silver nanoparticles. The spectrum between 3600 cm−1 and 
3250 cm−1 represents the stretching band of the amine groups. The peaks at 2924 cm−1 and 
2848 cm−1 can be attributed to asymmetric CH3 and symmetric CH2 vibrations, respec-
tively. The peak at 1730 cm−1 is assigned to the ester carbonyl C = O stretching mode. In 
addition, the peak at 1279 cm−1 occurs because of C-N stretching and N-H bending. More-
over, as consistent with the literature, nearly the same spectrum was observed for AgNP 
containing P(3HB)/P(3HO-co-3HD) nanofibers [39,63,64]. 
Figure 5. SEM images of AgNP-containing P(3HB)/P(3HO-co-3HD) nanofibers obtained by pro-
tocol 3 with magnifications (a) ×12,000, (b) ×25,000, (c) ×100,000 exhibit the uniform and dense
immobilization of AgNPs on the nanofibers.
FTIR-ATR spectra of neat P(3 B)/P(3HO-co-3HD) nanofibers and Ag P-loaded
P(3HB)/P(3HO-co-3HD) nanofibers are given in Figure S3. There is no considerable shift of
the peaks in the presence of silver nanoparticles. The spectrum bet een 3600 c 1 and
3250 cm−1 represents the stretching band of the a ine gro s. e eaks at 2924 c 1 and
2848 c 1 can be ttri te to asymmetric CH3 and symmetric CH2 vibrations, respectively.
The peak at 1730 cm−1 is assigned to the ester carbonyl C = O stretching mode. In ad ition,
the peak at 1279 cm−1 oc urs be au e of C-N stretching and N-H bending. Moreover, as
consistent w th the literature, ne rly the same spectrum was observed for AgNP c ntaining
P(3HB)/P(3HO-co-3HD) nanofibers [39,63,64].
The AgNP deposition on the P(3HB)/P(3HO-co-3HD) nanofibers was also character-
ized by UV-Vis spectroscopy. While AgNP containing P(3HB)/P(3HO-co-3HD) nanofibers
show a strong absorbance peak at 417 nm, neat P(3HB)/P(3HO-co-3HD) nanofibers do
not show any peaks between 250–600 nm. This is in line with literature stating that the
characteristic silver surface plasmon resonance band is attributed to the maxima between
400 and 420 nm, depending on the size of the particle, stabilizing molecules, and dielectric
constant of the medium [39,46,64,65] and thus confirms the deposition of AgNPs on the
nanofibers (Figure 6). The peak at 221 nm can be associated with the presence of ester
groups in the polymer structure [66].
Materials 2021, 14, 4907 12 of 17
Materials 2021, 14, x FOR PEER REVIEW 12 of 17 
 
 
The AgNP deposition on the P(3HB)/P(3HO-co-3HD) nanofibers was also character-
ized by UV-Vis spectroscopy. While AgNP containing P(3HB)/P(3HO-co-3HD) nanofibers 
show a strong absorbance peak at 417 nm, neat P(3HB)/P(3HO-co-3HD) nanofibers do not 
show any peaks between 250–600 nm. This is in line with literature stating that the char-
acteristic silver surface plasmon resonance band is attributed to the maxima between 400 
and 420 nm, depending on the size of the particle, stabilizing molecules, and dielectric 
constant of the medium [39,46,64,65] and thus confirms the deposition of AgNPs on the 
nanofibers (Figure 6). The peak at 221 nm can be associated with the presence of ester 
groups in the polymer structure [66]. 
 
Figure 6. UV-Visible spectroscopy of neat P(3HB)/P(3HO-co-3HD) nanofibers (red) and AgNP con-
taining P(3HB)/P(3HO-co-3HD) nanofibers (black). P(3HB)/P(3HO-co-3HD) nanofibers with AgNPs 
show a strong absorbance peak at 417 nm pointing out the AgNPs existence; however, neat 
P(3HB)/P(3HO-co-3HD) nanofibers do not show any peaks between 250 and 600 nm. 
The biological activity of the AgNP-containing nanofibers was further examined. Al-
amar Blue assay was performed after a 24 h presence of HaCaT cell culture on the sub-
strates. This shows that both the plain and the AgNP-containing P(3HB)/P(3HO-co-3HD) 
nanofibers did not show significant cytotoxic activity, which is in fact indicated by a dye 
reduction of 100% and 105%, respectively. Keratinocytes, which completely cover the out-
most layer of our body, lead the immune reaction (i.e., innate immune response and in-
flammation) in the skin by the production of pro-inflammatory, anti-inflammatory and 
antimicrobial (i.e., defensins) molecules in response to injury and external stimulation. 
The complexity of immune reactions occurs via the production those cytokines and anti-
bacterial molecules with a different time scale, which ultimately ensures an efficient tissue 
response to foreign agents. 
Different from the plain P(3HB)/P(3HO-co-3HD) nanofibers, which did not show ap-
preciable differences in the basal production of these molecules by HaCaT cells in culture, 
the AgNP-containing P(3HB)/P(3HO-co-3HD) nanofibers were able to upregulate the 
most important proinflammatory cytokines after 6 h, namely, IL-1(α and β), IL-6 and IL-
8, in order to initiate the healing process (Figure 7). Later on, 24 h after being in contact 
with the cells, all the above-mentioned ILs are reduced. In contrast, TNF-α expression is 
only observed at 24 h. TNF-α is an essential mediator in inflammation by recruiting in-
flammatory cells [67]. It also acts on platelet adhesiveness, favoring the formation of 
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containing P(3HB)/P(3HO-co-3HD) nanofibers (black). P(3HB)/P(3HO-co-3HD) nanofibers with
AgNPs show a strong absorbance peak at 417 nm pointing out the AgNPs existence; however, neat
P(3HB)/P(3HO-co-3HD) nanofibers do not show any peaks between 250 and 600 nm.
The biological activity of the AgNP-containing nanofibers was further examined.
Alamar Blue assay was performed after a 24 h presence of HaCaT cell culture on the
substrates. This shows that both the plain and the AgNP-containing P(3HB)/P(3HO-co-
3HD) nanofibers did not show significant cytotoxic activity, which is in fact in icated by
a ye reduction of 100% and 105%, respectively. Keratinocytes, which completely cover the
outmost layer of our body, lead the immune reaction (i.e., innate immune response and
infla mation) in the skin by the production of r -i fla at r , ti-i fl t
i l (i.e., defensins) molecules in response to injury and external stimulation. The
complexity of immune reactions occurs via the producti n those cyt kines and antibacterial
mol cules with a different tim scale, which ultimately ensur s an efficient tissue respons
to foreign agents.
fr the plain P(3HB)/P(3HO-co-3HD) anofibers, w ich did not show
appreciable differences in the basal producti n of these molecules by HaCaT cells in cul-
ure, the AgNP-containing P(3HB)/P(3HO-co-3HD) nanofibers wer able to upregulat
the most important proinflammatory cytokines after 6 h, namely, IL-1(α and β), IL-6 and
IL-8, in order to initiate the healing process (Figure 7). Later on, 24 h after i i t t
it t lls, ll t e above- entioned ILs are reduced. In contrast, TNF-α expression
is only observed at 24 h. TNF-α is an essential mediator i inflammation by recruiting
infla matory cells [67]. It also acts on platelet a hesiveness, favoring the for ation of
thro bus to reduce bacterial invasion and infection processes. The odulation (na ely,
initial upregulation, follo ed by a do nregulation) of pro-infla atory cytokines can
play a very useful role in wound healing. Indeed, the absence of proper healing has been
attributed to a number of factors dealing with inefficient timing and extent of the inflam-
matory cascade [68,69]. Most importantly, the AgNP-containing P(3HB)/P(3HO-co-3HD)
nanofibers can induce the mRNA production of HBD-2, thus stimulating the innate defense
capability of the skin from harmful entities. This aspect is very relevant in the wound
repair processes. In addition, such an indirect antimicrobial activity is desirable as the need
for antibiotic drugs is reduced. The TGF β expression was insignificantly downregulated.
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4. Conclusions 
The aim of this study was to produce wound dressing prototypes from bio-based 
polymers, namely PHAs. Only very thin layers of pure P(3HO-co-3HD) scaffolds could be 
prepared from the eco-friendly solvent system, as the fibers were fused due to the low Tg 
and elastomeric nature of the polymer. The morphology and elasticity of the nanofibers 
were optimized by blending P(3HO-co-3HD) with P(3HB), which has a higher Tg but lacks 
Figure 7. Relative gene expression of IL-1 (specifically, IL-1α and IL-1β), IL-6, IL-8, TNF-α, TGF-β
by HaCaT cells in contact with P(3HB)/P(3HO-co-3HD)/Ag for 6 h and 24 h. Data are reported
as mean ± SD and are expressed as percentage of increment relative to untreated HaCaT cells (as
controls; CTRL).
In addition, HaCaT cells were able to express cytokeratin upon culture for 7 days onto
the plain and Ag-loaded P(3HB)/P(3HO-co-3HD), as shown in Figure 8. This is a hall print
of appropriate keratinocyte function, which is predictive of re-epithelization capacity [70].
In the presence of AgNPs, we could observe a dense expression of cytokeratin by HaCaT
cells maintaining the squamous epithelial morphotype (Figure 8b) suggesting a good
cytocompatibility.
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ti i e le ing (3 -co-3 D) ith P(3 B), hich has a higher Tg t l
appropriate mechanical properties required for wound dressing applications due to its
more brittle nature. Since P(3HB) had poor solubility in eco-friendly solvents, a chlorinated
solvent-based system consisting of chloroform and 2-butanol was utilized for the electro-
spinning process, and P(3HB)/P(3HO-co-3HD) nanofibers with an average diameter of
410 ± 180 nm could be obtained. Afterwards, the surface of the fabricated P(3HB)/P(3HO-
co-3HD) nanofibers was modified with AgNPs via a dip-coating method. The amount
of AgNPs on the P(3HB)/P(3HO-co-3HD) nanofibers was determined as 18.05 wt% and
5.29 atomic % by EDX characterization. Metabolic activity, immunomodulatory, indirect
antimicrobial activity and cytokeratin expression of both the modified nanofibers were
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examined in vitro using HaCaT cells, revealing the potential ability to effectively contribute
to the wound healing process. In fact, also in presence of AgNPs, the metabolic activity of
the cells was above 100%. Moreover, the most important ILs were modulated in 24 h, and
HBD-2 was upregulated with respect to the basal condition of HaCaT cells specifically in
Ag-loaded P(3HB)/P(3HO-co-3HD). Finally, a proper keratinocyte function was confirmed
by the expression of cytokeratin at a protein level after 7 days in culture. These prelimi-
nary findings highlight the suitability of the produced AgNP-functionalized PHA-based
nanofibers for biomedical applications, particularly as wound dressings.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ma14174907/s1, Figure S1: Gas Chromatography Mass Spectrometry (GCMS) results of
(a) P(3HB), (b) P(3HO-co-3HD), Figure S2: 13C Nuclear Magnetic Resonance (NMR) results of
(a) P(3HB), (b) P(3HO-co-3HD), Figure S3: FTIR-ATR spectrum of neat P(3HB)/P(3HO-co-3HD)
nanofibers (black) and AgNP-containing P(3HB)/P(3HO-co-3HD) nanofibers (red), Figure S4: SEM
images of AgNP-containing P(3HB)/P(3HO-co-3HD) nanofibers obtained by (a) protocol 1, (b) proto-
col 2. Images with higher magnifications are given as insets.
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